Investigación Traslacional de Enfermidades da Vía Aérea
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoPublicacións en colaboración con investigadores/as de AstraZeneca (United Kingdom) (3)
2024
-
Tezepelumab decreases airway epithelial IL-33 and T2-inflammation in response to viral stimulation in patients with asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 79, Núm. 3, pp. 656-666
2012
-
Factors associated with health-related quality of life in adults with asthma. A cross-sectional study
Multidisciplinary Respiratory Medicine, Vol. 7, Núm. 5
2010
-
Factors associated with asthma control in primary care patients: The CHAS study
Archivos de Bronconeumologia, Vol. 46, Núm. 7, pp. 358-363